<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03731195</url>
  </required_header>
  <id_info>
    <org_study_id>GB01/18UCC</org_study_id>
    <nct_id>NCT03731195</nct_id>
  </id_info>
  <brief_title>GentleTouch (Study to Evaluate Somatosensory Evoked Potential (SSEP) Responses to Affective Touch and How it Develops in Healthy Term Babies)</brief_title>
  <official_title>GentleTouch (Study to Evaluate Somatosensory Evoked Potential (SSEP) Responses to Affective Touch and How it Develops in Healthy Term Babies)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University College Cork</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University College London - Institute of Child Health (UCL-ICH)</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Science Foundation Ireland</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Johnson &amp; Johnson</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>University College Cork</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will attempt to measure the direct effect of pleasant skin touch on the developing
      infant brain. The massage intervention stimulates a specific class of unmyelinated C-fibres
      in the skin called C-touch (CT) afferents, and effects will be assessed by monitoring brain
      responses (GentleTouch Project) in a prospective cohort study.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a single-centre proof of concept translational study to determine how and when
      Somato-sensory evoked potentials develop over the first 4 months of life.

      The aim of this study is to explore if the investigators can measure the cortical response
      from the scalp of infants using standard non-invasive EEG techniques, due to the activation
      of CT afferents and explore how the cortical response changes in regard to age. Preform a
      longitudinal study on 40 subjects at approximately 4 weeks and 4 months of age. The Gentle
      Touch study will examine the effect of gentle positive stimuli applied to an infant's forearm
      on cortical responses at two time points within the first 4 months of life.
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">May 9, 2018</start_date>
  <completion_date type="Anticipated">March 2020</completion_date>
  <primary_completion_date type="Anticipated">January 31, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Measurement and development of SSEP response to positive touch stimuli</measure>
    <time_frame>4 weeks</time_frame>
    <description>Standard Evoked Potentials</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Measurement of SSEP to positive touch stimuli</measure>
    <time_frame>4 months</time_frame>
    <description>Standard Evoked Potentials</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Neurodevelopmental Assessment</measure>
    <time_frame>4 months</time_frame>
    <description>Griffiths Mental Development Scales (GMDS)Griffiths III provides an overall measure of a child's development, as well as an individual profile of strengths and needs across five areas:
Foundations of Learning
Language and Communication
Eye and Hand Coordination
Personal-Social-Emotional
Gross Motor
Very Superior 16-20 Scaled Score &gt;130 Development Quotient Superior 14- &lt;16 Scaled Score 120 - 129 Development Quotient Above Average 12- &lt;14 Scaled Score 110 - 119 Development Quotient Average 8- &lt;12 Scaled Score 90 - 109 Development Quotient Below Average 6- &lt;8 Scaled Score 80 - 89 Development Quotient Borderline 4- &lt;6 Scaled Score 70 - 79 Development Quotient Extremely Low 0- &lt;4 Scaled Score â‰¤ 69 Development Quotient</description>
  </secondary_outcome>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Pleasant Touch</condition>
  <condition>Cortical Response</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Healthy Term infants &gt;37 weeks Gestational Age
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Infants born &gt; 37 weeks gestation

          -  Single births

          -  Not requiring admission to the Neonatal Unit

          -  Healthy infants without suspected congenital or metabolic anomalies

          -  Written Informed Consent

        Exclusion Criteria:

          -  Infants born &lt; 37 weeks gestation

          -  Multiple births

          -  Severe metabolic or genetic anomaly that would require ongoing specialist care in the
             infancy period.

          -  Admission to the Neonatal Unit.

          -  No written Informed Consent obtained
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>37 Weeks</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ronit Pressler, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University College London - Institute of Child Health (UCL-ICH)</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Cork University Maternity Hospital</name>
      <address>
        <city>Wilton</city>
        <state>Cork</state>
        <zip>T12 DC4A</zip>
        <country>Ireland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University College London - Institute of Child Health (UCL-ICH)</name>
      <address>
        <city>London</city>
        <zip>WC1N 1EH</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Ireland</country>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>August 2019</verification_date>
  <study_first_submitted>November 2, 2018</study_first_submitted>
  <study_first_submitted_qc>November 5, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">November 6, 2018</study_first_posted>
  <last_update_submitted>August 1, 2019</last_update_submitted>
  <last_update_submitted_qc>August 1, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">August 5, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University College Cork</investigator_affiliation>
    <investigator_full_name>Professor Geraldine Boylan</investigator_full_name>
    <investigator_title>Professor of Neonatal Physiology and Director of INFANT Centre</investigator_title>
  </responsible_party>
  <keyword>Baby Massage</keyword>
  <keyword>SSEP</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

